These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2173517)

  • 1. 3-(Cyclohexenonyl)-4-(4-hydroxyphenyl)-hexanes: antiandrogenes derived from the estrogen hexestrol.
    Schiller CD; Schneider MR; von Angerer E
    Arch Pharm (Weinheim); 1990 Jul; 323(7):417-20. PubMed ID: 2173517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
    Hartmann RW
    J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
    Hartmann RW; Heindl A; Schönenberger H
    J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes.
    Hartmann RW; Buchborn H; Kranzfelder G; Schönenberger H; Bogden A
    J Med Chem; 1981 Oct; 24(10):1192-7. PubMed ID: 6276542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain.
    Landvatter SW; Katzenellenbogen JA
    J Med Chem; 1982 Nov; 25(11):1300-7. PubMed ID: 6292423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.
    Zablocki JA; Katzenellenbogen JA; Carlson KE; Norman MJ; Katzenellenbogen BS
    J Med Chem; 1987 May; 30(5):829-38. PubMed ID: 3033242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 1. Synthesis and estrogen receptor binding affinity of 2,2'- and 3,3'-disubstituted hexestrols.
    Hartmann RW; Schwarz W; Schönenberger H
    J Med Chem; 1983 Aug; 26(8):1137-44. PubMed ID: 6308256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel hexestrol and diethylstilbestrol derivatives as potential anticancer and estrogenic agents.
    Ibrahim ES; Omar AM; Khalil MA; Makar MA; Soliman MT; Daabees TT
    Pharmazie; 1980 Feb; 35(2):80-4. PubMed ID: 6247720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic ester derivatives of the mammary tumor inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
    Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
    Arch Pharm (Weinheim); 1990 Feb; 323(2):121-4. PubMed ID: 2159273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor based imaging agents. 2. Synthesis and receptor binding affinity of side-chain halogenated hexestrol derivatives.
    Goswami R; Harsy SG; Heiman DF; Katzenellenbogen JA
    J Med Chem; 1980 Sep; 23(9):1002-8. PubMed ID: 6251218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo.
    Landvatter SW; Kiesewetter DO; Kilbourn MR; Katzenellenbogen JA; Welch MJ
    Life Sci; 1983 Nov; 33(19):1933-8. PubMed ID: 6316052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH analog of the estrogen hexestrol.
    Terenius L
    J Med Chem; 1970 Nov; 13(6):1246-7. PubMed ID: 5479884
    [No Abstract]   [Full Text] [Related]  

  • 16. Thiourea and thiosemicarbazide derivatives structurally related to hexestrol: synthesis and anticancer and other pharmacological properties.
    Omar AM; Farghaly AM; Hazzai AA; Eshba NH; Sharabi FM; Daabees TT
    J Pharm Sci; 1981 Sep; 70(9):1075-9. PubMed ID: 6101219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol.
    Ouellet R; Rousseau J; Brasseur N; van Lier JE; Diksic M; Westera G
    J Med Chem; 1984 Apr; 27(4):509-13. PubMed ID: 6323712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, receptor binding, and fluorescence properties of hexestrol-fluorophore conjugates: evaluation of site of attachment, fluorophore structure, and fluorophore-ligand spacing.
    Fevig TL; Lloyd JE; Zablocki JA; Katzenellenbogen JA
    J Med Chem; 1987 Jan; 30(1):156-65. PubMed ID: 3027331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential antineoplastics, 6. Synthesis of hexestrol derivatives with alkylating side chains].
    Hamacher H; Mangold C
    Arch Pharm (Weinheim); 1983; 316(3):271-81. PubMed ID: 6305306
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine mechanisms of suppressive effect of low dose estrogen-antiandrogen treatment on androgen-dependent organs of male rats.
    Reznikov AG; Varga SV; Chaikovskaya LV; Tarasenko LV; Polyakova LI
    J Endocrinol Invest; 1996 Nov; 19(10):654-8. PubMed ID: 9007695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.